Suchergebnisse - (Subject:"CD8-Positive T-Lymphocytes")

PubPharm (14)

1

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor

enthalten in: Journal for immunotherapy of cancer | 2023

von Shimizu, K. | Ueda, S. | Kawamura, M. | +4

2

Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine

enthalten in: Journal for immunotherapy of cancer | 2023

von Tran, C. | Lynch, K. | Meneveau, M. | +3

3

Vaccines for immunoprevention of DNA mismatch repair deficient cancers

enthalten in: Journal for immunotherapy of cancer | 2022

von Hernandez-Sanchez, A. | Grossman, M. | Yeung, K. | +3

4

Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2022

von Tseng, S. | Cheng, M. | Farmer, E. | +6

5

Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens

enthalten in: Journal for immunotherapy of cancer | 2022

von Bekri, S. | Rodney-Sandy, R. | Gruenstein, D. | +5

6

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2021

von Hernandez, R. | LaPorte, K. | Hsiung, S. | +2

7

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide

enthalten in: Journal for immunotherapy of cancer | 2021

von Shenderov, E. | Kandasamy, M. | Gileadi, U. | +7

8

Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma

enthalten in: Oncoimmunology | 2021

von Zhang, X. | Huck, K. | Jähne, K. | +11

9

IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors

enthalten in: Journal for immunotherapy of cancer | 2021

von Beyranvand Nejad, E. | Labrie, C. | van Elsas, M. | +8

10

CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors

enthalten in: Journal for immunotherapy of cancer | 2021

von Karaki, S. | Blanc, C. | Tran, T. | +19